Christian Erick Palavecino
Overview
Explore the profile of Christian Erick Palavecino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bravo A, Fuentealba F, Gonzalez I, Palavecino C
Pharmaceutics
. 2025 Jan;
16(12).
PMID: 39771604
is a Gram-negative bacillus responsible for a wide variety of potentially fatal infections and, in turn, constitutes a critical agent of healthcare-associated infections. Moreover, is characterized by multi-drug-resistant (MDR) bacteria,...
2.
Rubilar-Huenchuman M, Ortega-Villanueva C, Gonzalez I, Palavecino C
Pharmaceutics
. 2024 Jun;
16(6).
PMID: 38931945
spp. are Gram-positive bacteria that cause mild to severe infections, many associated with the oral cavity, such as periapical infections and healthcare-associated infections (HAIs). Many of these infections become serious...
3.
Yanten N, Vilches S, Palavecino C
Photodiagnosis Photodyn Ther
. 2023 Sep;
44:103803.
PMID: 37709240
Background: Pseudomonas aeruginosa is a Gram-negative bacillus that causes superficial and deep infections, which can be minor to life-threatening. Recently, P. aeruginosa has gained significant relevance due to the increased...
4.
Bustamante V, Palavecino C
Photodiagnosis Photodyn Ther
. 2023 Jul;
43:103709.
PMID: 37459942
Background: Acinetobacter baumannii is a Gram-negative, non-fermenting coccobacillus of the Moraxellaceae family. It is an opportunistic pathogen responsible for several hospital-acquired infections (HAIs) associated with skin and tissue infections at...
5.
Hormazabal D, Reyes A, Castro F, Cabrera A, Dreyse P, Melo-Gonzalez F, et al.
Biomed Pharmacother
. 2023 Jun;
164:114949.
PMID: 37267640
Multidrug-resistant bacteria, such as ESBL producing-Klebsiella pneumoniae, have increased substantially, encouraging the development of complementary therapies such as photodynamic inactivation (PDI). PDI uses photosensitizer (PS) compounds that kill bacteria using...
6.
Gonzalez I, Palavecino A, Nunez C, Dreyse P, Melo-Gonzalez F, Bueno S, et al.
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834303
Background: Extended-spectrum beta-lactamase (ESBL) and carbapenemase (KPC) producing are multidrug-resistant bacteria (MDR) with the highest risk to human health. The significant reduction of new antibiotics development can be overcome by...
7.
Nunez C, Palavecino A, Gonzalez I, Dreyse P, Palavecino C
Pharmaceutics
. 2021 Apr;
13(5).
PMID: 33922077
Background: The extended-spectrum beta-lactamase (ESBL) is one of the leading causes of health-associated infections (HAIs), whose antibiotic treatments have been severely reduced. Moreover, HAI bacteria may harbor pathogenic factors such...
8.
Perez C, Zuniga T, Palavecino C
Photodiagnosis Photodyn Ther
. 2021 Apr;
34:102285.
PMID: 33836278
Background: Staphylococcus aureus is a Gram-positive spherical bacterium that commonly causes various infections which can range from superficial to life-threatening. Hospital strains of S. aureus are often resistant to antibiotics,...
9.
Bustamante V, Gonzalez I, Dreyse P, Palavecino C
Photodiagnosis Photodyn Ther
. 2020 Sep;
32:102020.
PMID: 32977066
Background: Due to increased bacterial multi-drug resistance (MDR), there is an antibiotic depletion to treat infectious diseases. Consequently, other promising options have emerged, such as the antimicrobial photodynamic inactivation therapy...
10.
Valenzuela-Valderrama M, Carrasco-Veliz N, Gonzalez I, Dreyse P, Palavecino C
Photodiagnosis Photodyn Ther
. 2020 Jun;
31:101882.
PMID: 32565179
Background: Carbapenemase-producing strains of Klebsiella pneumoniae (KPC) are one of the multi-drug resistant bacteria with the highest risk for human health. The colistin is the only antibiotic option against KPC;...